ToxNetwork.com
Consulting in Toxicology, Carcinogenesis, Pharmacology, and Pharmacy Standard of Care

Harry A. Milman, Ph.D.

                CARCINOGENESIS

Capabilities

• Litigation Support; Expert Witness
     - Defense (52%); Plaintiff (48%)
     - Depositions; Jury Trial Testimony
     - Cancer Causation
           A.  Genotoxic Carcinogens
           B.  Non-Genotoxic Carcinogens
  
  

• VA Disability Claims
      - Agent Orange
      - Chemical exposures at Camp Lejeune -- benzene, trichloroethylene, perchloroethylene
      - Other chemical exposures
      - Drug and chemical toxicity
      - Chemical causes of cancer
  
  

• Chemical carcinogens...
     - in Air, Water, Food
     - at Work
     - at Home
     - in Consumer Products
     - in plastics -- e.g., phthalates
     - in FEMA Trailers -- e.g., formaldehyde
  
  

• Medical Records Review
  
  

• Over 250 Chemicals of Interest including:
      Benzene
      Bisphenol-A (BPA)
      Chlorinated solvents
      DEHP
      1,2-Dichloroethane
      Formaldehyde
      Lead
      Metals
      Methylene chloride
      Perchloroethylene (PERC)
      Phthalates
      Terephthalic acid
      Toluene
      Trichloroethylene (TCE)
      Xylene
      ...and many more
  
  
  

• Regulatory Submissions --  EPA, FDA

Experience

• Provided Expert Witness deposition and jury trial testimony and litigation support in cancer causation for Defense and Plaintiff since 1998.

• 10 years as a Research Scientist and Pharmacologist at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) conducting research on cancer treatment, childhood leukemia, pancreatic cancer, chemical carcinogenesis, carcinogen testing, and toxicology.

• Nearly 20 years as a Senior Toxicologist/Senior Science Advisor at the US Environmental Protection Agency (EPA) evaluating numerous submissions of cancer and toxicology information in support of regulatory activities and managing research projects in chemical carcinogenesis and toxicology.

• Nearly three years as a Senior Pharmacologist/Toxicologist in the NCI Carcinogenesis Testing Program designing, monitoring and reporting of long-term animal cancer studies.

• Prepared draft guidelines on "Risk-Risk Tradeoff" at the EPA

• Coordinated scientific activities on chemical carcinogenesis and toxicology between the EPA, the National Toxicology Program (NTP), the Agency for Toxic Substances and Disease Registry (ATSDR), various other Federal agencies, and national and international health organizations including the World Health Organization (WHO) and the International Program on Chemical Safety (IPCS)

• Published 5 books, over 70 peer reviewed, scientific papers and abstracts and numerous governmental reports in carcinogenesis and toxicology.

Relevant Scientific Publications

• Milman, H.A., Bosland, M.C., Walden, P.D. and Heinze, J.E.:  Evaluation of the adequacy of published studies of low dose effects of bisphenol A (BPA) on the rodent prostate for use in human risk assessment.  Regul. Toxicol. Pharmacol. 35:338-346 (2002).

• Milman, H.A., and Heinze, J.E.:  Evaluation of the relationship between children's health and exposure to endocrine disrupters.  Abstracts, 3rd Annual Meeting of the Japan Society of Endocrine Disrupters Research.  PE-18:336 (2000).

• Handbook of Carcinogen Testing, New Jersey:  Noyes Publications (1985; 1994)

• Markers of Chemically Induced Cancer, New Jersey:  Noyes Publications (1984)

• Application of Biological Markers to Carcinogen Testing, New York and London:  Plenum Publishing Corp. (1983)

• Biochemical Mechanisms and Regulation of Intercellular Communication, New Jersey:  Princeton Scientific Co., Inc.  (1988)

• Over 70 peer reviewed, scientific papers and abstracts and numerous governmental reports (see PUBLICATIONS) 

Contact:
ToxNetwork.com

  Back to Top

   © Copyright 2000; 2005 ToxNetwork.com
Revised January 2008